{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T18:01:59Z","timestamp":1694628119012},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl."],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s00103-008-0586-6","type":"journal-article","created":{"date-parts":[[2008,6,30]],"date-time":"2008-06-30T15:11:56Z","timestamp":1214838716000},"page":"782-786","source":"Crossref","is-referenced-by-count":7,"title":["Progestin and breast cancer"],"prefix":"10.1007","volume":"51","author":[{"given":"Cecylia","family":"Giersig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"586_CR1","doi-asserted-by":"crossref","first-page":"9929","DOI":"10.1158\/0008-5472.CAN-07-1103","volume":"67","author":"Liang","year":"2007","unstructured":"Liang Y, Besch-Williford C, Brekken RA, Hyder SM (2007) Progestin-dependent progression of human breast tumour xenografts: a novel model for evaluating antitumor therapeutics. Cancer Res 67(20):9929\u20139936","journal-title":"Cancer Res"},{"key":"586_CR2","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1126\/science.1130471","volume":"314","author":"Jovanovic","year":"2006","unstructured":"Jovanovic Poole A, Li Y, Kim Y, et al. (2006) Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist. Science 314:1467\u20131470","journal-title":"Science"},{"key":"586_CR3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1677\/erc.1.01010","volume":"13","author":"Wiebe","year":"2006","unstructured":"Wiebe JP (2006) Progesterone metabolites in breast cancer. Endocrine Related Cancer 13:717\u2013738","journal-title":"Endocrine Related Cancer"},{"key":"586_CR4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jsbmb.2006.03.010","volume":"100","author":"Wiebe","year":"2006","unstructured":"Wiebe JP, Souter L, Zhang G (2006) Dutasteride affects progesterone metabolizing enzyme activity\/ expression in human breast cell lines resulting in suppression of cell proliferation and detachment J Steroid Biochem Mol Biol 100(4\u20135):129\u2013140","journal-title":"J Steroid Biochem Mol Biol"},{"key":"586_CR5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jsbmb.2004.12.003","volume":"93","author":"Wiebe","year":"2005","unstructured":"Wiebe JP, Lewis MJ, Cialacu V, et al. (2005) The role of progesterone metabolites in breast cancer: potential for new diagnostics and therapeutics. J Steroid Biochem Mol Biol 93(2\u20135):201\u2013208","journal-title":"J Steroid Biochem Mol Biol"},{"key":"586_CR6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.brainres.2004.06.025","volume":"1020","author":"Maayan","year":"2004","unstructured":"Maayan R, Fisch B, Galdor M, et al. (2004) Influence of 17beta-estradiol on the synthesis of reduced neurosteroids in the brain (in vivo) and in glioma cells (in vitro): possible relevance to mental disorders in women. Brain Res 1020(1\u20132):167\u2013172","journal-title":"Brain Res"},{"key":"586_CR7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1042\/bj2850557","volume":"285","author":"Liang","year":"1992","unstructured":"Liang T, Liao S (1992) Inhibition of steroid 5xreductase by specific aliphatic unsaturated fatty acids. Biochem J 285:557\u2013562","journal-title":"Biochem J"},{"key":"586_CR8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00689711","volume":"34","author":"Chajes","year":"1995","unstructured":"Chajes V, Sattler W, Stranzl A, Kostner GM (1995) Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: relationship to peroxides and Vitamin-E. Breast Cancer Res Treatment 34:199\u2013212","journal-title":"Breast Cancer Res Treatment"},{"key":"586_CR9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1023\/A:1018435229087","volume":"15","author":"Jiang","year":"1997","unstructured":"Jiang WG, Singhrao SK, Hiscox S, et al. (1997) Regulation of desmosomal cell adhesion in human tumour cells by polyunsaturated fatty acids. Clin Exp Metastasis 15:593\u2013602","journal-title":"Clin Exp Metastasis"},{"key":"586_CR10","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jsbmb.2005.09.008","volume":"98","author":"Moore","year":"2006","unstructured":"Moore MR, Spence JB, Kiningham KK, Dillon JL (2006) Progestin inhibition of cell death in human breast cancer cell lines. Journal of Steorid Biochemistry & Molecular Biology 98(4\u20135):218\u2013227","journal-title":"Journal of Steorid Biochemistry & Molecular Biology"},{"key":"586_CR11","first-page":"C16","volume":"104","author":"Zylka-Menhorn","year":"2007","unstructured":"Zylka-Menhorn V (2007) R\u00fcckgang der Brustkrebsinzidenz: \u201eEine Kausalit\u00e4t l\u00e4sst sich aus den Daten nicht sicher ableiten\u201c. Dtsch \u00c4rztebl 104:C16\u201317","journal-title":"Dtsch \u00c4rztebl"},{"key":"586_CR12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"Writing","year":"2002","unstructured":"Writing Group for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA 288:321\u2013333","journal-title":"JAMA"},{"key":"586_CR13","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","volume":"289","author":"Women","year":"2003","unstructured":"Women's Health Initiative Randomized Trial (2003) Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. JAMA 289:3243\u20133253","journal-title":"JAMA"},{"key":"586_CR14","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","volume":"291","author":"The","year":"2004","unstructured":"The Women's Health Initiative Steering Committee (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative Randomized Controlled Trial. JAMA 291:1701\u20131712","journal-title":"JAMA"},{"key":"586_CR15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1023\/A:1008909128110","volume":"10","author":"Persson","year":"1999","unstructured":"Persson I, Weiderpass E, Bergkvist L, et al. (1999) Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement. Cancer Causes Control 10(4):253\u2013260","journal-title":"Cancer Causes Control"},{"key":"586_CR16","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","volume":"347","author":"Collaborative","year":"1996","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53.297 women with breast cancer and 100.239 women without breast cancer from 54 epidemiological studies. Lancet 347(9017):1713\u20131727","journal-title":"Lancet"},{"key":"586_CR17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1158\/1055-9965.EPI-04-0376","volume":"14","author":"Milne","year":"2005","unstructured":"Milne RL, Knight JA, John EM, et al. (2005) Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers 14(2):350\u2013356","journal-title":"Cancer Epidemiol Biomarkers"},{"key":"586_CR18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/oxfordjournals.aje.a010219","volume":"151","author":"Shapiro","year":"2000","unstructured":"Shapiro S, Rosenberg L, Hoffman M, et al. (2000) Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen\/progestogen contraceptives. Am J Epidemiol 151(4):396\u2013403","journal-title":"Am J Epidemiol"},{"key":"586_CR19","first-page":"1375","volume":"11","author":"Kumle","year":"2002","unstructured":"Kumle M, Weiderpass E, Braaten T, et al. (2002) Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study. Cancer Epidemiol Biomarkers Prev 11(11):1375\u20131381","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"586_CR20","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/01.AOG.0000178754.88912.b9","volume":"106","author":"Backman","year":"2005","unstructured":"Backman T, Rauramo I, Jaakkola K, et al. (2005) Use of the levonorgestrel-releasing intrauterine system and breast cancer. Obstet Gynecol 106(4):813\u2013817","journal-title":"Obstet Gynecol"},{"key":"586_CR21","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1200\/JCO.2007.11.3084","volume":"25","author":"Agrawal","year":"2007","unstructured":"Agrawal G, Chen JH, Baick CH, et al. (2007) Pathological complete response in triple negative poorly differentiated invasive ductal breast carcinoma detected during pregnancy. J Clin Oncol 25(18):2618\u20132660","journal-title":"J Clin Oncol"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-008-0586-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00103-008-0586-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-008-0586-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T03:16:30Z","timestamp":1558581390000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00103-008-0586-6"}},"subtitle":["The missing pieces of a puzzle"],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["586"],"URL":"https:\/\/doi.org\/10.1007\/s00103-008-0586-6","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}